About Us
AlgometRx, Inc. is a medical device startup, spun out from Children’s National Hospital in 2015, by pediatric anesthesiologist Julia Finkel, MD. Pain is often treated empirically, with drugs being used in a trial and error fashion leading to lack of efficacy, increased healthcare costs, unnecessary side effects, tolerance, and abuse—all pointing to the need for more objective assessment and better monitoring of the impact of analgesics.
Our Technology
The AlgometRx Nociometer® enables a fundamental paradigm shift in pain assessment and analgesic prescribing. Our novel technology and algorithms analyze pupil dilation in response to neuroselective stimulation to formulate a nociceptive profile. This new construct is used to characterize pain type, intensity and assess the pharmacodynamic impact of analgesics. The Nociometer platform technology can be applied to any population.
Our Vision
Addressing Pain Points
Characterization
The Nociometer provides an objective characterization of pain type and intensity.
Treatment
Objective pain characterization helps clinicians make more informed treatment decisions.
Personalized Medicine
The Nociometer enables personalized pain treatment tailored to the specific needs of each individual patient.
Drug Development
The Nociometer will enhance clinical trials for analgesics and other drug classes by making them faster, more efficient, and more precise.
Contact Us
Let's Connect and Innovate Together